• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用机器学习预测分化型甲状腺癌对放射性碘的良好反应。

Predicting excellent response to radioiodine in differentiated thyroid cancer using machine learning.

机构信息

Department of Nuclear Medicine, Recep Tayyip Erdogan University, Faculty of Medicine, Training and Research Hospital, Rize, Turkey.

出版信息

Acta Otorhinolaryngol Ital. 2024 Aug;44(4):261-268. doi: 10.14639/0392-100X-N3029.

DOI:10.14639/0392-100X-N3029
PMID:39347551
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441520/
Abstract

OBJECTIVE

If excellent response (ER) occurs after radioactive iodine (RAI) treatment in patients with differentiated thyroid carcinoma (DTC), the recurrence rate is low. Our study aims to predict ER at 6-24 months after RAI by using machine learning (ML) methods in which clinicopathological parameters are included in patients with DTC without distant metastasis.

METHODS

Treatment response of 151 patients with DTC without distant metastasis and who received RAI treatment was determined (ER/nonER). Thyroidectomy ± neck dissection pathology data, laboratory, and imaging findings before and after RAI treatment were introduced to ML models.

RESULTS

After RAI treatment, 118 patients had ER and 33 had nonER. Before RAI treatment, TgAb was positive in 29% of patients with ER and 55% of patients with nonER (p = 0.007). Eight of the ML models predicted ER with high area under the ROC curve (AUC) values (> 0.700). The model with the highest AUC value was extreme gradient boosting (AUC = 0.871), the highest accuracy shown by gradient boosting (81%).

CONCLUSIONS

ML models may be used to predict ER in patients with DTC without distant metastasis.

摘要

目的

分化型甲状腺癌(DTC)患者在接受放射性碘(RAI)治疗后出现极好的反应(ER),则复发率较低。本研究旨在通过机器学习(ML)方法,预测无远处转移的 DTC 患者在 RAI 治疗后 6-24 个月的 ER,其中包括临床病理参数。

方法

确定 151 例无远处转移且接受 RAI 治疗的 DTC 患者的治疗反应(ER/非 ER)。将甲状腺切除术±颈部解剖病理数据、RAI 治疗前后的实验室和影像学发现引入 ML 模型。

结果

RAI 治疗后,118 例患者 ER,33 例患者非 ER。在 RAI 治疗前,ER 患者中有 29%的人 TgAb 阳性,而非 ER 患者中有 55%的人 TgAb 阳性(p = 0.007)。8 种 ML 模型预测 ER 的曲线下面积(AUC)值较高(>0.700)。具有最高 AUC 值的模型是极端梯度增强(AUC = 0.871),梯度增强的准确率最高(81%)。

结论

ML 模型可用于预测无远处转移的 DTC 患者的 ER。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/11441520/d410afe4df62/aoi-2024-04-261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/11441520/3c4333f185fe/aoi-2024-04-261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/11441520/d410afe4df62/aoi-2024-04-261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/11441520/3c4333f185fe/aoi-2024-04-261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4fb/11441520/d410afe4df62/aoi-2024-04-261-g002.jpg

相似文献

1
Predicting excellent response to radioiodine in differentiated thyroid cancer using machine learning.运用机器学习预测分化型甲状腺癌对放射性碘的良好反应。
Acta Otorhinolaryngol Ital. 2024 Aug;44(4):261-268. doi: 10.14639/0392-100X-N3029.
2
Is Stimulated Thyroglobulin Before Radioiodine Therapy a Useful Tool in Predicting Response to Initial Therapy in Patients with Differentiated Thyroid Carcinoma?放射性碘治疗前促甲状腺球蛋白是否可作为预测分化型甲状腺癌初始治疗反应的有用工具?
Horm Metab Res. 2024 Sep;56(9):641-648. doi: 10.1055/a-2318-5320. Epub 2024 May 21.
3
Low activity versus high activity: noninferior response to radioiodine therapy in differentiated patients with extrathyroid extension.低活性与高活性:分化型甲状腺外侵犯患者对放射性碘治疗的非劣效反应
Nucl Med Commun. 2017 May;38(5):366-371. doi: 10.1097/MNM.0000000000000666.
4
Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma.预测中高危甲状腺乳头状癌患者放射性碘治疗反应的因素。
BMC Endocr Disord. 2024 Jul 15;24(1):112. doi: 10.1186/s12902-024-01648-8.
5
Comparing therapeutic outcomes: radioactive iodine therapy versus non-radioactive iodine therapy in differentiated thyroid cancer.比较治疗效果:分化型甲状腺癌的放射性碘治疗与非放射性碘治疗。
Front Endocrinol (Lausanne). 2024 Sep 20;15:1442714. doi: 10.3389/fendo.2024.1442714. eCollection 2024.
6
Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.比较不同剂量放射性碘消融治疗中高危分化型甲状腺癌患者的效果。
Ann Nucl Med. 2019 Jul;33(7):495-501. doi: 10.1007/s12149-019-01357-6. Epub 2019 Apr 6.
7
Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.分化型甲状腺癌淋巴结复发。淋巴结清扫术后辅助放射性碘治疗的作用。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):926-934. doi: 10.1007/s00259-016-3593-0. Epub 2016 Dec 14.
8
A predictive model for L-T4 dose in postoperative DTC after RAI therapy and its clinical validation in two institutions.RAI 治疗后分化型甲状腺癌术后 L-T4 剂量的预测模型及其在两个机构的临床验证。
Front Endocrinol (Lausanne). 2024 Aug 20;15:1425101. doi: 10.3389/fendo.2024.1425101. eCollection 2024.
9
Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.青少年与成年患者远处转移性分化型甲状腺癌(DTC)的放射性碘(RAI)治疗
Endocr J. 2015;62(12):1067-75. doi: 10.1507/endocrj.EJ15-0451. Epub 2015 Oct 1.
10
Outcomes of Low-Risk Differentiated Thyroid Cancer (DTC) without Radioactive Iodine (RAI) Ablation Therapy Post-Thyroidectomy: An Experience from a Tertiary Centre in Karachi.低危分化型甲状腺癌(DTC)患者在甲状腺切除术后不进行放射性碘(RAI)消融治疗的结局:来自卡拉奇一家三级中心的经验。
J Coll Physicians Surg Pak. 2024 Aug;34(8):968-973. doi: 10.29271/jcpsp.2024.08.968.

本文引用的文献

1
Thyroid cartilage infiltration in advanced laryngeal cancer: prognostic implications and predictive modelling.晚期喉癌的甲状腺软骨浸润:预后意义和预测模型。
Acta Otorhinolaryngol Ital. 2024 Jun;44(3):176-182. doi: 10.14639/0392-100X-N2739. Epub 2023 Dec 29.
2
Artificial Intelligence in Head and Neck Cancer: A Systematic Review of Systematic Reviews.人工智能在头颈部肿瘤中的应用:系统评价的系统评价。
Adv Ther. 2023 Aug;40(8):3360-3380. doi: 10.1007/s12325-023-02527-9. Epub 2023 Jun 8.
3
From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment.
从模式到患者:癌症诊断、预后和治疗的临床机器学习进展。
Cell. 2023 Apr 13;186(8):1772-1791. doi: 10.1016/j.cell.2023.01.035. Epub 2023 Mar 10.
4
Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients.鼻窦癌临床病理信息的重组是否能改善预后分层及放化疗敏感性预测?一项针对145例患者的回顾性研究。
Front Oncol. 2022 Jun 3;12:799680. doi: 10.3389/fonc.2022.799680. eCollection 2022.
5
Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine.分化型甲状腺癌的淋巴结转移大于 5 个且转移淋巴结比例大于 0.30 预测对放射性碘的反应。
Cancer Med. 2021 Nov;10(21):7610-7619. doi: 10.1002/cam4.4288. Epub 2021 Oct 8.
6
Outcomes after radioiodine ablation in patients with thyroid cancer: Long-term follow-up of a Chinese randomized clinicaltrial.甲状腺癌患者放射性碘消融治疗后的结局:一项中国随机临床试验的长期随访。
Clin Endocrinol (Oxf). 2021 Nov;95(5):782-789. doi: 10.1111/cen.14563. Epub 2021 Aug 8.
7
The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer.消融术后非刺激状态下甲状腺球蛋白在分化型甲状腺癌中的预后作用
Cancers (Basel). 2021 Jan 15;13(2):310. doi: 10.3390/cancers13020310.
8
Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients: Is Thyroglobulin Stimulation Required?中间风险甲状腺癌患者的治疗反应评估:是否需要促甲状腺球蛋白刺激?
Thyroid. 2020 Jun;30(6):863-870. doi: 10.1089/thy.2019.0431. Epub 2020 Mar 2.
9
UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.N1b 期甲状腺乳头状癌患者接受放射性碘治疗的不良反应:一项倾向评分匹配研究。
Endocr Pract. 2019 Dec;25(12):1286-1294. doi: 10.4158/EP-2019-0155. Epub 2019 Aug 14.
10
Risk Factors for Indeterminate Response After Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer.分化型甲状腺癌患者放射性碘治疗后不确定反应的危险因素。
Clin Nucl Med. 2019 Sep;44(9):714-718. doi: 10.1097/RLU.0000000000002653.